Results 31 to 40 of about 31,515 (266)

Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non-Research Clinical Setting: A Multicentre Italian Experience. [PDF]

open access: yesMycoses
ABSTRACT Background Invasive fungal infections (IFI) are a prominent cause of morbidity and mortality among patients with haematological malignancies (HMs). Diagnostic work‐up excluding IFI is mandatory in case of persistent fever while antifungal treatment (AFT) is started.
Marianna C   +29 more
europepmc   +2 more sources

Variability in antifungal and antiviral use in hospitalized children [PDF]

open access: yes, 2017
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S   +6 more
core   +2 more sources

P-1049. Retrospective Analysis on the Efficacy and Adverse Effects of Antifungal Prophylaxis in Patients with Peritoneal Dialysis-Associated Peritonitis [PDF]

open access: goldOpen Forum Infect Dis
Vidal Luchana   +7 more
europepmc   +2 more sources

Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia. [PDF]

open access: yes, 2010
To describe the frequency of diagnosis of cryptococcosis among HIV-infected patients in Phnom Penh, Cambodia, at programme entry, to investigate associated risk factors, and to determine the incidence of cryptococcal ...
Amornkul   +24 more
core   +2 more sources

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

open access: yesBlood Advances, 2019
: The combination of venetoclax with hypomethylating agents (VEN-HMAs) showed promising activity in newly diagnosed and relapsed/refractory (r/r) acute myeloid leukemia (AML).
Ibrahim Aldoss   +17 more
doaj   +1 more source

Antifungal prophylaxis during neutropenia and immunodeficiency [PDF]

open access: yesClinical Microbiology Reviews, 1997
Fungal infections represent a major source of morbidity and mortality in patients with almost all types of immunodeficiencies. These infections may be nosocomial (aspergillosis) or community acquired (cryptococcosis), or both (candidiasis). Endemic mycoses such as histoplasmosis, coccidioidomycosis, and penicilliosis may infect many immunocompromised ...
O, Lortholary, B, Dupont
openaire   +2 more sources

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

open access: yesCritical Care, 2021
Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF).
Stefan Hatzl   +17 more
doaj   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Antifungal prophylaxis in liver transplant recipients [PDF]

open access: yesLiver Transplantation, 2009
Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection.
Eschenauer, Gregory A.   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy